标题
Cardiac toxicity in cancer survivors
作者
关键词
-
出版物
CANCER
Volume 119, Issue -, Pages 2131-2142
出版商
Wiley
发表日期
2013-05-21
DOI
10.1002/cncr.28061
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trastuzumab-Related Cardiac Dysfunction
- (2017) Melinda L. Telli et al. Journal of the National Comprehensive Cancer Network
- The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors
- (2012) E. Sieswerda et al. ANNALS OF ONCOLOGY
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge
- (2012) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Late Cardiac Effects of Cancer Treatment
- (2012) Daniel J. Lenihan et al. JOURNAL OF CLINICAL ONCOLOGY
- Progression of Heart Failure From AHA/ACC Stage A to Stage B or Even C
- (2012) Daniel J. Lenihan JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
- (2012) Jersey Chen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins in Preparation for Chemotherapy
- (2012) Daniel J. Lenihan JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Second Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy
- (2012) Lois B. Travis et al. JNCI-Journal of the National Cancer Institute
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
- (2011) Heloisa Sawaya et al. AMERICAN JOURNAL OF CARDIOLOGY
- Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
- (2011) Navneet S. Majhail et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation
- (2011) S. H. Armenian et al. BLOOD
- Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors
- (2011) S. Bhatia CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cardiovascular Disease
- (2011) Ming Hui Chen et al. CIRCULATION RESEARCH
- Status and Prospects for Discovery and Verification of New Biomarkers of Cardiovascular Disease by Proteomics
- (2011) Robert E. Gerszten et al. CIRCULATION RESEARCH
- The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium
- (2011) Lynda M. Vrooman et al. EUROPEAN JOURNAL OF CANCER
- Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
- (2011) Luigi Tarantini et al. JOURNAL OF CARDIAC FAILURE
- Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib
- (2011) Christopher J. Richards et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy
- (2011) Nazanin Fallah-Rad et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer
- (2011) Florentine S.M. Hilbers et al. RADIOTHERAPY AND ONCOLOGY
- Newest Echocardiographic Techniques for the Detection of Cardiotoxicity and Heart Failure During Chemotherapy
- (2011) Heloisa Sawaya et al. Heart Failure Clinics
- Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
- (2011) Bonnie Ky et al. Heart Failure Clinics
- Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines
- (2010) D. Bovelli et al. ANNALS OF ONCOLOGY
- Anticancer therapy induced cardiotoxicity: review of the literature
- (2010) Sandra Geiger et al. ANTI-CANCER DRUGS
- Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
- (2010) C.-L. Sun et al. BLOOD
- Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation
- (2010) S. L. Galper et al. BLOOD
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- Adjuvant trastuzumab in routine clinical practice and the impact of cardiac monitoring guidelines on treatment delivery
- (2010) L.J. Murray et al. BREAST
- Cardiovascular Risk Factors in Adult Survivors of Pediatric Cancer--A Report from the Childhood Cancer Survivor Study
- (2010) L. R. Meacham et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage
- (2010) Carrie Anna Geisberg et al. CURRENT HYPERTENSION REPORTS
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- HFSA 2010 Comprehensive Heart Failure Practice Guideline
- (2010) Heart Failure Society of America JOURNAL OF CARDIAC FAILURE
- Role of Three-Dimensional Echocardiography in Breast Cancer: Comparison With Two-Dimensional Echocardiography, Multiple-Gated Acquisition Scans, and Cardiac Magnetic Resonance Imaging
- (2010) Jonathan Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies
- (2010) Geoffrey J. Yoon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anthracycline-Induced Cardiomyopathy
- (2010) Daniela Cardinale et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
- Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity
- (2010) Lu Fan et al. Pharmacogenetics and Genomics
- The Compelling Need for a Cardiology and Oncology Partnership and the Birth of the International CardiOncology Society
- (2010) Daniel J. Lenihan et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity
- (2010) Daniela Cardinale et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
- (2010) Douglas B. Sawyer et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
- (2009) A L Jones et al. BRITISH JOURNAL OF CANCER
- Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer
- (2009) Xianglin L. Du et al. CANCER
- Two Nonsynonymous Single Nucleotide Polymorphisms of Human Carbonyl Reductase 1 Demonstrate Reduced in Vitro Metabolism of Daunorubicin and Doxorubicin
- (2009) O. S. Bains et al. DRUG METABOLISM AND DISPOSITION
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
- (2009) Sharon Ann Hunt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular toxicity caused by cancer treatment: strategies for early detection
- (2009) Renske Altena et al. LANCET ONCOLOGY
- Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations
- (2009) M. Martin et al. ONCOLOGIST
- Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems
- (2008) B. R.J. H. Bird et al. CLINICAL CANCER RESEARCH
- Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors-Retrospective cohort analyses and a concept for prospective intervention
- (2008) Anne Andersson et al. INTERNATIONAL JOURNAL OF CANCER
- Anthracycline Cardiotoxicity: From Bench to Bedside
- (2008) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Left Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?
- (2008) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma
- (2008) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
- (2008) Martee L. Hensley et al. JOURNAL OF CLINICAL ONCOLOGY
- New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients
- (2008) Marianne Ryberg et al. JNCI-Journal of the National Cancer Institute
- Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity
- (2007) Peter James O’Brien TOXICOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now